Barriers to community engagement during the response to an Ebola virus disease outbreak in Uganda. [PDF]
Musoke D+9 more
europepmc +1 more source
Vesicular Release of Ebola Virus Matrix Protein VP40
Joanna Timmins+3 more
openalex +1 more source
Ophthalmic Sequelae of Ebola Virus Disease in Survivors, Sierra Leone. [PDF]
Choo CH+13 more
europepmc +1 more source
Charting a novel path towards Ebola virus disease preparedness: Considerations for preventive vaccination. [PDF]
Guttieres D+5 more
europepmc +1 more source
Vaccine Potential of Ebola Virus VP24, VP30, VP35, and VP40 Proteins
Julie A. Wilson+3 more
openalex +1 more source
The Assembly of Ebola Virus Nucleocapsid Requires Virion-Associated Proteins 35 and 24 and Posttranslational Modification of Nucleoprotein [PDF]
Yue Huang+3 more
openalex +1 more source
Reactive oxygen species-related oxidative changes are associated with splenic lymphocyte depletion in Ebola virus infection. [PDF]
Mani V+21 more
europepmc +1 more source
Infectivity-Enhancing Antibodies to Ebola Virus Glycoprotein
Ayato Takada+4 more
openalex +1 more source
The oral drug obeldesivir protects nonhuman primates against lethal Ebola virus infection. [PDF]
Woolsey C+16 more
europepmc +1 more source